{"cord_uid": "agc89fqv", "sha": "9e38a1b572034071df752844aaed131a5893209b", "source_x": "Elsevier; Medline; PMC", "title": "Drug repositioning is an alternative for the treatment of coronavirus COVID-19", "doi": "10.1016/j.ijantimicag.2020.105969", "pmcid": "PMC7194941", "pubmed_id": "32278811", "license": "els-covid", "abstract": "Abstract Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.", "publish_time": "2020-04-09", "authors": "Serafin, Marissa B.; Bottega, Angelita; Foletto, Vit\u00f3ria S.; da Rosa, Taci\u00e9li F.; H\u00f6rner, Andreas; H\u00f6rner, Rosmari", "journal": "Int J Antimicrob Agents", "mag_id": "", "who_covidence_id": "", "arxiv_id": "", "pdf_json_files": ["document_parses/pdf_json/9e38a1b572034071df752844aaed131a5893209b.json"], "pmc_json_files": ["document_parses/pmc_json/PMC7194941.xml.json"], "url": "https://www.sciencedirect.com/science/article/pii/S0924857920301266; https://www.ncbi.nlm.nih.gov/pubmed/32278811/; https://api.elsevier.com/content/article/pii/S0924857920301266; https://doi.org/10.1016/j.ijantimicag.2020.105969", "s2_id": "215748975"}